lifestyle.thedishh.com

Author: Inovio Pharmaceuticals, Inc.

INOVIO to Participate in Upcoming Scientific Conferences

March 9, 2026
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

March 5, 2026
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

March 4, 2026
INOVIO to Participate in Upcoming Scientific and Investor Conferences

February 12, 2026
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

December 29, 2025
INOVIO Reports Inducement Grant Under Inducement Plan

December 21, 2025
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

November 5, 2025
INOVIO Reports Inducement Grant Under Inducement Plan

November 3, 2025
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

October 27, 2025
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

October 24, 2025